BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, April 21, 2025
Breaking News: Trump administration impacts
Breaking News: Trump administration impacts
Breaking News: Trump administration impacts
Breaking News: Trump administration impacts
Home
»
Topics
» BioWorld Science, Neurology/psychiatric
BioWorld Science, Neurology/psychiatric
RSS
Asahi discloses anxiolytic/cognition-enhancing drugs
May 3, 1996
Eisai returns sumatriptan rights to Glaxo Wellcome
May 3, 1996
Phase III data for Quadramet presented at ASCO
May 3, 1996
Zambon claims (S)-ibuprofen composition
May 3, 1996
Droxidopa studied in patients with chronic pain
May 3, 1996
MM-218 selected for development in emesis, diarrhea
April 26, 1996
Promising clinical results reported for CRF
April 26, 1996
NMDA/glycine-site antagonists revealed by RPR
April 26, 1996
Lilly claims mGluR antagonists for neurodegeneration
April 26, 1996
OPC-14523 improves learning in preclinical models
April 26, 1996
Previous
1
2
…
2728
2729
2730
2731
2732
2733
2734
2735
2736
…
2739
2740
Next
RSS